Kidney function may affect heart drug dosing – new study completed
NCT ID NCT06775834
First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 28 times
Summary
This study tested how the drug HRS-1893 is processed in people with mild or moderate kidney problems compared to healthy volunteers. The goal was to see if kidney function changes drug levels in the body, helping doctors recommend the right dose for patients with hypertrophic cardiomyopathy. 24 adults aged 18-65 took part in this phase 1 trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTROPHIC CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sichuan Provincial People's Hospital
Chengdu, Sichuan, 610072, China
Conditions
Explore the condition pages connected to this study.